Pediatric Spine: Will The Tether Pull Zimmer Biomet Spine Out of the Doldrums?

article image

The Tether is a potential game-changer for pediatric scoliosis patients. What does it say about the feasibility of undertaking pediatric device innovation, and what does it mean to Zimmer Biomet’s struggling spine division?

The August 2019 FDA approval of Zimmer Biomet’s The Tether vertebral body tethering system is a “game-changer” for a subset of pediatric scoliosis patients and a bright spot for the manufacturer’s troubled spine business, which continues to flounder years after the disruptive merger of two orthopedic giants. It also spotlights the challenges and opportunities of getting a truly innovative pediatric device onto the market.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: